Click it and Unblock the Notifications
Just In
Don't Miss
-
T20 World Cup: 'He will definitely be in my list' - Anjum Chopra handpicks 2 wicketkeeper-batters for India squad -
Salman Khan Case: Actor Arrives In 'X' Cr Car At Airport With Tight Security Days After House Firing Incident -
Closing Bell: Market Stages Smart Recovery, Sensex & Nifty Snap 4-Day Losing Streak Led By HDFC Bank -
Tata Motors To Manufacture Jaguar Land Rover Cars In Billion Dollar TN Plant - Report -
OnePlus Ace 3 Pro Leak Hints at New Design; Expected Launch, Specifications We Know So Far -
Summer Fashion: Your Bollywood Style White Outfits Guide To Keep It Cool And Chic -
Journey From Delhi To Ooty: Top Transport Options And Attractions -
IIIT-Bangalore Introduces PG Diploma In Digital Product Design And Management
Covid-19: Brazil suspends Bharat Biotech's Covaxin clinical trials
Hyderabad, July 24: Brazilhas suspended the clinical studies of Bharat Biotech''s COVID-19 vaccine, Covaxin following termination of the company''s agreement with its partner there, the South American Country''s health regulator said.
Bharat Biotech on Friday announced cancellation of the MoU it signed with Precisa Medicamentos and Envixia Pharmaceuticals LL.C for its COVID-19 vaccine Covaxin for the Brazilian market. The termination of the pact comes after the deal with the Brazilian government for supply of 20 million doses of the vaccine landed in controversy and attracted investigation by authorities in that country.
''In the Coordination of Clinical Research at Anvisa (Copec/GGMED) determined this Friday (23/7) the precautionary suspension of clinical studies of the Covaxin vaccine in Brazil.
The suspension was carried out as a result of a statement from the Indian company Bharat Biotech Limited International, sent to Anvisa on Friday (23/7), Anvisa, the Brazilian health regulator, said on Friday.
Precisa Medicamentos was Bharat Biotechs partner in Brazil, providing assistance, guidance and support with regulatory submissions, licensure, distribution, insurance and conduct of phase III clinical trials, among others. Following the graft allegations, the Brazilian government has suspended Covaxin''s order temporarily.
